Cargando…

Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate

BACKGROUND: Multimetal organic frameworks (M-MOFs) were synthesized by including a second metal ion with the main base metal in the synthesis process to enhance their applications for drug delivery. Aceclofenac (ACF), a nonsteroidal anti-inflammatory analgesic drug of low aqueous solubility, was sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Haydar, Muder, Abid, Hussein Rasool, Sunderland, Bruce, Wang, Shaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305134/
https://www.ncbi.nlm.nih.gov/pubmed/30587925
http://dx.doi.org/10.2147/DDDT.S182983
_version_ 1783382497071988736
author Al Haydar, Muder
Abid, Hussein Rasool
Sunderland, Bruce
Wang, Shaobin
author_facet Al Haydar, Muder
Abid, Hussein Rasool
Sunderland, Bruce
Wang, Shaobin
author_sort Al Haydar, Muder
collection PubMed
description BACKGROUND: Multimetal organic frameworks (M-MOFs) were synthesized by including a second metal ion with the main base metal in the synthesis process to enhance their applications for drug delivery. Aceclofenac (ACF), a nonsteroidal anti-inflammatory analgesic drug of low aqueous solubility, was selected as a candidate for the drug delivery system PURPOSE: This study aimed to evaluate the loading capacity (LC) and entrapment efficiency (EE) percentages of multi-Material of Institute Lavoisier (MIL)-100(Fe) (M-MIL-100(Fe)) for ACF. MATERIALS AND METHODS: Hydrothermal synthesis procedure was used to prepare multi-MIL-100(Fe) samples (Zn I-MIL-100(Fe), Zn II-MIL-100(Fe), Ca I-MIL-100(Fe), Ca II-MIL-100-(Fe), Mg I-MIL-100(Fe), Mg II-MIL-100(Fe), Mn I-MIL-100(Fe), and Mn II-MIL-100(Fe)). The characterization of M-MIL-100(Fe) samples was evaluated by X-ray powder diffraction (XRD), Fourier transform infrared spectra, scanning electron microscope (SEM), TGA, and N(2) adsorption isotherms. The LC of M-MIL-100(Fe) and EE of ACF were determined. Nuclear magnetic resonance (NMR) and zeta-potential analyses were employed to confirm qualitatively the drug loading within M-MIL-100(Fe). RESULTS: The ACF LC of MIL-100(Fe) was 27%, whereas the LC of M-MIL-100(Fe) was significantly increased and ranged from 37% in Ca I-MIL-100(Fe) to about 57% and 59% in Mn II-MIL-100(Fe) and Zn II-MIL-100(Fe), respectively. The ACF@M-MOFs release profiles showed slow release rates in phosphate buffer solutions at pH 6.8 and 7.4 as compared to the ACF@MIL-100(Fe). CONCLUSION: Therefore, M-MOFs showed a significant potential as a carrier for drug delivery systems.
format Online
Article
Text
id pubmed-6305134
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63051342018-12-26 Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate Al Haydar, Muder Abid, Hussein Rasool Sunderland, Bruce Wang, Shaobin Drug Des Devel Ther Original Research BACKGROUND: Multimetal organic frameworks (M-MOFs) were synthesized by including a second metal ion with the main base metal in the synthesis process to enhance their applications for drug delivery. Aceclofenac (ACF), a nonsteroidal anti-inflammatory analgesic drug of low aqueous solubility, was selected as a candidate for the drug delivery system PURPOSE: This study aimed to evaluate the loading capacity (LC) and entrapment efficiency (EE) percentages of multi-Material of Institute Lavoisier (MIL)-100(Fe) (M-MIL-100(Fe)) for ACF. MATERIALS AND METHODS: Hydrothermal synthesis procedure was used to prepare multi-MIL-100(Fe) samples (Zn I-MIL-100(Fe), Zn II-MIL-100(Fe), Ca I-MIL-100(Fe), Ca II-MIL-100-(Fe), Mg I-MIL-100(Fe), Mg II-MIL-100(Fe), Mn I-MIL-100(Fe), and Mn II-MIL-100(Fe)). The characterization of M-MIL-100(Fe) samples was evaluated by X-ray powder diffraction (XRD), Fourier transform infrared spectra, scanning electron microscope (SEM), TGA, and N(2) adsorption isotherms. The LC of M-MIL-100(Fe) and EE of ACF were determined. Nuclear magnetic resonance (NMR) and zeta-potential analyses were employed to confirm qualitatively the drug loading within M-MIL-100(Fe). RESULTS: The ACF LC of MIL-100(Fe) was 27%, whereas the LC of M-MIL-100(Fe) was significantly increased and ranged from 37% in Ca I-MIL-100(Fe) to about 57% and 59% in Mn II-MIL-100(Fe) and Zn II-MIL-100(Fe), respectively. The ACF@M-MOFs release profiles showed slow release rates in phosphate buffer solutions at pH 6.8 and 7.4 as compared to the ACF@MIL-100(Fe). CONCLUSION: Therefore, M-MOFs showed a significant potential as a carrier for drug delivery systems. Dove Medical Press 2018-12-18 /pmc/articles/PMC6305134/ /pubmed/30587925 http://dx.doi.org/10.2147/DDDT.S182983 Text en © 2019 Al Haydar et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Al Haydar, Muder
Abid, Hussein Rasool
Sunderland, Bruce
Wang, Shaobin
Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
title Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
title_full Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
title_fullStr Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
title_full_unstemmed Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
title_short Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
title_sort multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305134/
https://www.ncbi.nlm.nih.gov/pubmed/30587925
http://dx.doi.org/10.2147/DDDT.S182983
work_keys_str_mv AT alhaydarmuder multimetalorganicframeworksasdrugcarriersaceclofenacasadrugcandidate
AT abidhusseinrasool multimetalorganicframeworksasdrugcarriersaceclofenacasadrugcandidate
AT sunderlandbruce multimetalorganicframeworksasdrugcarriersaceclofenacasadrugcandidate
AT wangshaobin multimetalorganicframeworksasdrugcarriersaceclofenacasadrugcandidate